Enhancement of leukotriene B4 release in stimulated asthmatic neutrophils by platelet activating factor

Thorax

Volumn 52, Issue 12, 1997, Pages 1024-1029

  Shindo, Kunihiko ^a   Koide, Kohei ^a   Fukumura, Motonori ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Asthma; Leukotriene B4; Neutrophil; Platelet activating factor (PAF); Priming effect

Indexed keywords

CALCIMYCIN; CALCIUM; LEUKOTRIENE B4; LIPOXYGENASE; THROMBOCYTE ACTIVATING FACTOR; ARACHIDONATE 5 LIPOXYGENASE; IONOPHORE;

ADULT; ARTICLE; ASTHMA; CALCIUM CELL LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MALE; NEUTROPHIL; PNEUMONIA; PRIORITY JOURNAL; CELL CULTURE; CYTOSOL; DRUG EFFECT; IMMUNOLOGY; METABOLISM; MIDDLE AGED; SECRETION; STIMULATION;

ADULT; ARACHIDONATE 5-LIPOXYGENASE; ASTHMA; CALCIMYCIN; CALCIUM; CELLS, CULTURED; CYTOSOL; FEMALE; HUMANS; IONOPHORES; LEUKOTRIENE B4; MALE; MIDDLE AGED; NEUTROPHILS; PLATELET ACTIVATING FACTOR; STIMULATION, CHEMICAL;

EID: 0030608692     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.52.12.1024     Document Type: Article

References (39)

1. Benveniste J, Henson PM, Cochrane CG. Leukocyte dependent histamine release from rabbit platelets: the role of IgE, basophils and a platelet-activating factor. J Exp Med 1972;136:1356-77.
2. 4, platelet-activating factor and 5-HETE. J Cell Physiol 1985;122:229-39.
3. 4 synthesis in human polymorphonuclear leukocytes. J Clin Invest 1982; 70:1058-65.
4. Chung KF. Platelet-activating factor in inflammation and pulmonary disorders. Clin Sci 1992;83:127-38.
5. Spence DPS, Johnston SL, Calverly PMA, Dhillon P, Higgins C, Ramhamadany E, et al. The effect of the orally active platelet-activating factor antagonist WEB 2086 in the treatment of asthma. Am J Respir Crit Care Med 1994; 149:1142-8.
6. Kuitert LM, Angus RM, Barnes NC, Barnes PJ, Bone MF, Fan Chung K, et al. Effect of a novel potent platelet-activating factor antagonist, Modipafant, in clinical asthma. Am J Respir Crit Care Med 1995;151:1331-5.
7. Miwa M, Miyake T, Yamaoka T, Sugatani J, Suzuki Y, Sakata S, et al. Characterization of serum platelet-activating factor (PAF) acetylhydrolase: correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children. J Clin Invest 1988;82:1983-91.
8. Stafforini DM, Satoh K, Atkinson DL, Tjoelker LW, Eberhardt C, Yoshida H, et al. PAF acetylhydrolase deficiency: a mis-sense mutation near the active site of an anti-inflammatory phospholipase. J Clin Invest 1996;97:2784-91.
9. Tsukioka K, Matsuzaki M, Nakamata M, Kayahara H. Increased plasma levels of platelet-activating factor (PAF) and low serum PAF acetylhydrolase (PAF-AH) activity in adult patients with bronchial asthma. Arerugi 1993;91: 650-7.
10. Nadel JA. Genetics reveals importance of platelet activating factor in asthma and possibly other inflammatory states. J Clin Invest 1996;97:2689-90.
11. Postma DS, Renkema TEJ, Noordhoek JA, Faber H, Sluiter HJ, Kauffman H. Association between nonspecific bronchial hyperreactivity and superoxide anion production by polymorphonuclear leukocytes in chronic air-flow obstruction. Am Rev Respir Dis 1988;137:57-61.
12. Meltzer S, Goldberg B, Lad P, Easton J. Superoxide generation and its modulation by adenosine on neutrophils of subjects with asthma. J Allergy Clin Immunol 1989;83: 960-6.
13. Neijens HJ, Raatgeep RE, Degenhart HJ, Duiverman EJ, Kerebinjn KF. Altered leukocyte response in relation to the basic abnormality in children with asthma and bronchial hyperresponsiveness. Am Rev Respir Dis 1984;130:744-7.
14. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987;136:225-44.
15. Boyum A. Isolation of mononuclear cells and granulocytes from blood. Scand J Clin Lab Invest 1968;21:77-89.
16. 4 hydrolase in human bronchoalveolar lavage fluid. J Clin Invest 1994;93:1042-50.
17. 4 in vitro and in vivo. J Immunol 1994;153:5750-9.
18. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72: 248-54.
19. Rouzer CA, Kargman S. Translocation of 5-lipoxygenase to the membrane in human leukocytes challenged with ionophore A23187. J Biol Chem 1988;263:10980-8.
20. Naccache PH, Faucher N, Caon AC, McColl SR. Propionic acid-induced calcium mobilization in human neutrophils. J Cell Physiol 1988;136:118-24.
21. Tsien RY. A non-disruptive technique for loading calcium buffers and indicators into cells. Nature (London) 1981; 290:527-8.
22. Pozzan T, Arslan P, Tsien RY, Rink TJ. Anti-immunoglobulin, cytoplasmic free calcium, and capping in B lymphocytes. J Cell Biol 1982;94:335-40.
23. White JR, Naccache PH, Molski TFP, Borgeat P, Shaafi RI. Direct demonstration of increased intracellular concentration of free calcium in rabbit and human neutrophils following stimulation by chemotactic factor. Biochem Biophys Res Commun 1983;113:44-50.
24. Conrad GW, Rink TJ. Platelet activating factor raises intracellular calcium ion concentration in macrophages. J Cell Biol 1986;103:439-50.
25. Chao W, Olson MS. Platelet-activating factor: receptors and signal transduction. Biochem J 1993;292:617-29.
26. O'Flaherty JT, Surles JR, Redman J, Jacobsen D, Piantadosi C, Wykle RL. Binding and metabolism of platelet-activating factor by human neutrophils. J Clin Invest 1986; 78:381-8.
27. Samuelsson B. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 1983; 220:568-75.
28. 4 in inflammation. Crit Rev Immunol 1990;10:1-12.
29. 4. Am J Respir Cell Mol Biol 1993; 8:493-9.
30. 4 antagonism in a primate model of asthma. J Clin Invest 1996;97:381-7.
31. Beaubien BB, Tippins JR, Morris HR. Platelet-activating factor stimulation of peptideleukotriene release: inhibition by vaso active polypeptide. Biochem Biophys Res Commun 1984;125:105-8.
32. 2+ in human neutrophils induced by opsonized particles. FEBS Lett 1989;259:209-12.
33. Rouzer CA, Samuelsson B. On the nature of the 5-lipoxygenase reaction in human leukocytes: enzyme purification and requirement for multiple stimulatory factors. Proc Natl Acad Sci 1985;82:6040-4.
34. Rouzer CA, Rands E, Kargman S, Jones RE, Register RB, Dixon RAF. Characterisation of cloned human leukocyte 5-lipoxygenase expressed in mammalian cells. J Biol Chem 1988;263:10135-40.
35. Lee T-C, Malone B, Snyder F. Stimulation of calcium uptake by 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) in rabbit platelets: possible involvement of the lipoxygenase pathway. Arch Biochem Biophys 1983; 223:33-9.
36. 4 from stimulated eosinophils of asthmatic patients. Thorax 1996;51:155-8.
37. Stenton SC, Court EN, Kingston WP, Goadby P, Kelly CA, Duddridge M, et al. Platelet activating factor in bronchoalveolar lavage fluid from asthmatic subjects. Eur Respir J 1990;3:408-13.
38. Scappaticci E, Libertucci D, Bottomicca F, Da Col R, Silvestro L, Tetta C, et al. Platelet-activating factor in bronchoalveolar lavage from patients with sarcoidosis. Am Rev Respir Dis 1992;146:433-8.
39. 4 and platelet-activating factor on human alveolar macrophage eicosanoid and PAF synthesis. Am Rev Respir Dis 1993;148:682-8.